Net loss of Orchid Pharma reported to Rs 5.72 crore in the quarter ended September 2025 as against net profit of Rs 27.24 crore during the previous quarter ended September 2024. Sales declined 13.10% to Rs 193.52 crore in the quarter ended September 2025 as against Rs 222.70 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 193.52 | 222.70 | -13 |
| OPM % | -0.76 | 13.62 | - |
| PBDT | 5.57 | 34.53 | -84 |
| PBT | -3.33 | 25.90 | PL |
| NP | -5.72 | 27.24 | PL |